Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37K Buy
+3,276
New +$62.9K ﹤0.01% 3835
2025
Q2
Sell
-42
Closed -$11K 2972
2025
Q1
$11K Buy
42
+26
+163% +$14.4K ﹤0.01% 2344
2024
Q4
$14K Buy
16
+2
+14% +$2.62K ﹤0.01% 2253
2024
Q3
$5K Buy
+14
New +$17.3K ﹤0.01% 2268
2021
Q4
Sell
-2
Closed -$183K 3515
2021
Q3
$183K Hold
2
﹤0.01% 2724
2021
Q2
$278K Buy
+2
New +$328K ﹤0.01% 2197

Other funds holding GNPX

HRT Financial's GNPX Position: Q2 2026 in Review

HRT Financial opened a new position in Genprex (GNPX) in Q2 2026: 3,276 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #3835 among its holdings. This is a return to the name: HRT Financial previously reported a position in GNPX as recently as Q1 2025.

HRT Financial first reported a position in GNPX in Q2 2021 and has held it in 6 quarters since. The position peaked at $278K in Q2 2021. 17 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • HRT Financial held 3,276 shares of Genprex worth $37K as of Q2 2026.
  • Genprex was a new HRT Financial position in Q2 2026.
  • Genprex made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3835 holding.
  • HRT Financial first reported a position in Genprex in Q2 2021 and has held it in 6 quarters since.
  • HRT Financial's Genprex position peaked at $278K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.